Archive for the ‘Pharmaceutical Research’ Category

Open PHACTS

Sunday, April 7th, 2013

Open PHACTS – Open Pharmacological Space

From the homepage:

Open PHACTS is building an Open Pharmacological Space in a 3-year knowledge management project of the Innovative Medicines Initiative (IMI), a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The project is due to end in March 2014, and aims to deliver a sustainable service to continue after the project funding ends. The project consortium consists of leading academics in semantics, pharmacology and informatics, driven by solid industry business requirements: 28 partners, including 9 pharmaceutical companies and 3 biotechs.

Sourcecode has just appeared on GibHub: OpenPHACTS.

Important to different communities for different reasons. My interest isn’t the same as BigPharma. ;-)

A project to watch as they navigate the thickets of vocabularies, ontologies and other semantically diverse information sources.

Mining the pharmacogenomics literature—a survey of the state of the art

Thursday, July 26th, 2012

Mining the pharmacogenomics literature—a survey of the state of the art by Udo Hahn, K. Bretonnel Cohen, and Yael Garten. (Brief Bioinform (2012) 13 (4): 460-494. doi: 10.1093/bib/bbs018)

Abstract:

This article surveys efforts on text mining of the pharmacogenomics literature, mainly from the period 2008 to 2011. Pharmacogenomics (or pharmacogenetics) is the field that studies how human genetic variation impacts drug response. Therefore, publications span the intersection of research in genotypes, phenotypes and pharmacology, a topic that has increasingly become a focus of active research in recent years. This survey covers efforts dealing with the automatic recognition of relevant named entities (e.g. genes, gene variants and proteins, diseases and other pathological phenomena, drugs and other chemicals relevant for medical treatment), as well as various forms of relations between them. A wide range of text genres is considered, such as scientific publications (abstracts, as well as full texts), patent texts and clinical narratives. We also discuss infrastructure and resources needed for advanced text analytics, e.g. document corpora annotated with corresponding semantic metadata (gold standards and training data), biomedical terminologies and ontologies providing domain-specific background knowledge at different levels of formality and specificity, software architectures for building complex and scalable text analytics pipelines and Web services grounded to them, as well as comprehensive ways to disseminate and interact with the typically huge amounts of semiformal knowledge structures extracted by text mining tools. Finally, we consider some of the novel applications that have already been developed in the field of pharmacogenomic text mining and point out perspectives for future research.

At thirty-six (36) pages and well over 200 references, this is going to take a while to digest.

Some questions to be thinking about while reading:

How are entity recognition issues same/different?

What techniques have you seen before? How different/same?

What other techniques would you suggest?

Network Science – NetSci

Monday, December 27th, 2010

Warning: NetSci has serious issues with broken links.

Network Science – NetSci: An Extensive Set of Resources for Science in Drug Discovery

From the website:

Welcome to the Network Science website. This site is dedicated to the topics of pharmaceutical research and the use of advanced techniques in the discovery of new therapeutic agents. We endeavor to provide a comprehensive look at the industry and the tools that are in use to speed drug discovery and development.

I stumbled across this website while looking for computational chemistry resources.

Pharmaceutical research is rich in topic map type issues, from mapping across the latest reported findings in journal literature to matching those identifications to results in computational software.

Questions:

  1. Develop a drug discovery account that illustrates how topic maps might or might not help in that process. (5-7 pages, citations)
  2. What benefits would a topic map bring to drug discovery and how would you illustrate those benefits for a grant application either to a pharmaceutical company or granting agency? (3-5 pages, citations)
  3. Where would you submit a grant application based on #2? (3-5 pages, citations) (Requires researching what activities in drug development are funded by particular entities.)
  4. Prepare a grant application based on the answer to #3. (length depends on grantor requirements)
  5. For extra credit, update and/or correct twenty (20) links from this site. (Check with me first, I will maintain a list of those already corrected.)